Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venu Menon

Showing results (241-250 of 347) with videos related to

Pageof 35
Sort By:
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Diabetes & Vascular Disease Research|April 25, 2019
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trialAnirudh Kumar, Divyang R Patel, Kathy E Wolski, et al.
The American Journal of Cardiology|September 16, 2020
Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic ShockAnirudh Kumar, Chetan P Huded, Leon Zhou, et al.
Journal of Cardiac Failure|December 28, 2020
Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic TherapyTrejeeve Martyn, Kathleen D Faulkenberg, Chonyang L Albert, et al.
Circulation|December 10, 2019
Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart AssociationAbdulla A Damluji, Daniel E Forman, Sean van Diepen, et al.
Journal of the American Heart Association|September 14, 2022
Outcomes Following Acute Coronary Syndrome in Patients With and Without Rheumatic Immune-Mediated Inflammatory DiseasesHeba Wassif, Marwan Saad, Rajul Desai, et al.
The Annals of Thoracic Surgery|March 27, 2023
Transcatheter vs Surgical Aortic Valve Replacement in Pure Native Aortic RegurgitationAmgad Mentias, Marwan Saad, Venu Menon, et al.
Circulation|March 4, 2021
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart AssociationTimothy D Henry, Matthew I Tomey, Jacqueline E Tamis-Holland, et al.
JACC. Advances|October 21, 2024
Characteristics and Outcomes of Patients With Valvular Cardiogenic ShockRaunak M Nair, Sanchit Chawla, Feras Alkhalaileh, et al.
Journal of the American Heart Association|November 23, 2019
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE TrialAnirudh Kumar, Divyang R Patel, Danielle M Brennan, et al.
Pageof 35

Showing results (241-250 of 347) with videos related to

Sort By:
Pageof 35
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Diabetes & Vascular Disease Research|April 25, 2019
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trialAnirudh Kumar, Divyang R Patel, Kathy E Wolski, et al.
The American Journal of Cardiology|September 16, 2020
Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic ShockAnirudh Kumar, Chetan P Huded, Leon Zhou, et al.
Journal of Cardiac Failure|December 28, 2020
Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic TherapyTrejeeve Martyn, Kathleen D Faulkenberg, Chonyang L Albert, et al.
Circulation|December 10, 2019
Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart AssociationAbdulla A Damluji, Daniel E Forman, Sean van Diepen, et al.
Journal of the American Heart Association|September 14, 2022
Outcomes Following Acute Coronary Syndrome in Patients With and Without Rheumatic Immune-Mediated Inflammatory DiseasesHeba Wassif, Marwan Saad, Rajul Desai, et al.
The Annals of Thoracic Surgery|March 27, 2023
Transcatheter vs Surgical Aortic Valve Replacement in Pure Native Aortic RegurgitationAmgad Mentias, Marwan Saad, Venu Menon, et al.
Circulation|March 4, 2021
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart AssociationTimothy D Henry, Matthew I Tomey, Jacqueline E Tamis-Holland, et al.
JACC. Advances|October 21, 2024
Characteristics and Outcomes of Patients With Valvular Cardiogenic ShockRaunak M Nair, Sanchit Chawla, Feras Alkhalaileh, et al.
Journal of the American Heart Association|November 23, 2019
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE TrialAnirudh Kumar, Divyang R Patel, Danielle M Brennan, et al.
Pageof 35